Online first
Letter to the Editor
Published online: 2024-07-23
The use of botulinum toxin in the treatment of androgenetic alopecia
1
, 1, 1
, 1, 1
DOI: 10.5603/fd.100354
Abstract
Not available
Keywords: androgenetic alopeciabotulinum toxinhair lossalopeciaquality of life
References
- Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine. 2017; 57(1): 9–17.
- Nestor MS, Ablon G, Gade A, et al. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021; 20(12): 3759–3781.
- Severi G, Sinclair R, Hopper JL, et al. Androgenetic alopecia in men aged 40–69 years: prevalence and risk factors. Br J Dermatol. 2003; 149(6): 1207–1213.
- Swerdloff RS, Dudley RE, Page ST, et al. Dihydrotestosterone: biochemistry, physiology, and clinical implications of elevated blood levels. Endocr Rev. 2017; 38(3): 220–254.
- Martinez-Jacobo L, Villarreal-Villarreal CD, Ortiz-López R, et al. Genetic and molecular aspects of androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2018; 84(3): 263–268.
- Rho NK, Han KH, Kim HS. An update on the cosmetic use of botulinum toxin: the pattern of practice among Korean dermatologists. Toxins (Basel). 2022; 14(5): 329.
- He J, Wang T, Dong J. Effectiveness of botulinum toxin A injection for the treatment of secondary axillary bromhidrosis. J Plast Reconstr Aesthet Surg. 2017; 70(11): 1641–1645.
- Freund BJ, Schwartz M. Treatment of male pattern baldness with botulinum toxin: a pilot study. Plast Reconstr Surg. 2010; 126(5): 246e–248e.
- Singh S, Neema S, Vasudevan B. A pilot study to evaluate effectiveness of botulinum toxin in treatment of androgenetic alopecia in males. J Cutan Aesthet Surg. 2017; 10(3): 163–167.
- Zhang Li, Yu Q, Wang Y, et al. A small dose of botulinum toxin A is effective for treating androgenetic alopecia in Chinese patients. Dermatol Ther. 2019; 32(4): e12785.
- Shon U, Kim MH, Lee DY, et al. The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism. J Am Acad Dermatol. 2020; 83(6): 1838–1839.
- Zhou Y, Yu S, Zhao J, et al. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia. Biomed Res Int. 2020: 1501893.
- Tian K, Gao S, Jia Z, et al. A study of combination unilateral subcutaneous botulinum toxin a treatment for androgenetic alopecia. J Cosmet Dermatol. 2022; 21(11): 5584–5590.
- Nassar A, Abdel-Aleem H, Samir M, et al. Efficacy of botulinum toxin A injection in the treatment of androgenic alopecia: A Comparative Controlled Study. J Cosmet Dermatol. 2022; 21(10): 4261–4268.
- Sansone-Bazzano G, Reisner RM, Bazzano G. Conversion of testosterone-1,2-3H to androstenedione-3H in the isolated hair follicle of man. J Clin Endocrinol Metab. 1972; 34(3): 512–515.
- Goldman BE, Fisher DM, Ringler SL. Transcutaneous PO2 of the scalp in male pattern baldness: a new piece to the puzzle. Plast Reconstr Surg. 1996; 97(6): 1109–1116; discussion 1117.
- Kwack MiH, Ahn JiS, Kim MK, et al. Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice. J Invest Dermatol. 2012; 132(1): 43–49.
- English RS, Ruiz S. Use of botulinum toxin for androgenic alopecia: a systematic review. Skin Appendage Disord. 2022; 8(2): 93–100.
